Literature DB >> 25749350

Systematic search for rare variants in Finnish early-onset colorectal cancer patients.

Tomas Tanskanen1, Alexandra E Gylfe1, Riku Katainen1, Minna Taipale2, Laura Renkonen-Sinisalo3, Heikki Järvinen4, Jukka-Pekka Mecklin5, Jan Böhm5, Outi Kilpivaara1, Esa Pitkänen1, Kimmo Palin1, Pia Vahteristo1, Sari Tuupanen1, Lauri A Aaltonen6.   

Abstract

The heritability of colorectal cancer (CRC) is incompletely understood, and the contribution of undiscovered rare variants may be important. In search of rare disease-causing variants, we exome sequenced 22 CRC patients who were diagnosed before the age of 40 years. Exome sequencing data from 95 familial CRC patients were available as a validation set. Cases with known CRC syndromes were excluded. All patients were from Finland, a country known for its genetically homogenous population. We searched for rare nonsynonymous variants with allele frequencies below 0.1% in 3,374 Finnish and 58,112 non-Finnish controls. In addition, homozygous and compound heterozygous variants were studied. No genes with rare loss-of-function variants were present in more than one early-onset CRC patient. Three genes (ADAMTS4, CYTL1, and SYNE1) harbored rare loss-of-function variants in both early-onset and familial CRC cases. Five genes with homozygous variants in early-onset CRC cases were found (MCTP2, ARHGAP12, ATM, DONSON, and ROS1), including one gene (MCTP2) with a homozygous splice site variant. All discovered homozygous variants were exclusive to one early-onset CRC case. Independent replication is required to associate the discovered variants with CRC. These findings, together with a lack of family history in 19 of 22 (86%) early-onset patients, suggest genetic heterogeneity in unexplained early-onset CRC patients, thus emphasizing the requirement for large sample sizes and careful study designs to elucidate the role of rare variants in CRC susceptibility.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic predisposition to disease; age of onset; colorectal neoplasms; exome sequencing

Mesh:

Year:  2014        PMID: 25749350     DOI: 10.1016/j.cancergen.2014.12.004

Source DB:  PubMed          Journal:  Cancer Genet


  9 in total

1.  CYTL1 Promotes the Activation of Neutrophils in a Sepsis Model.

Authors:  Haiyan Xue; Shu Li; Xiujuan Zhao; Fuzheng Guo; Lilei Jiang; Yaxin Wang; Fengxue Zhu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.

Authors:  Naim Abu Freha; Yaara Leibovici Weissman; Alexander Fich; Inbal Barnes Kedar; Marisa Halpern; Ignacio Sztarkier; Doron M Behar; Orly Arbib Sneh; Alex Vilkin; Hagit N Baris; Rachel Gingold; Flavio Lejbkowicz; Yaron Niv; Yael Goldberg; Zohar Levi
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

Review 3.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

4.  Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p, and 4q.

Authors:  Anthony M Musolf; Bilal A Moiz; Haiming Sun; Claudio W Pikielny; Yohan Bossé; Diptasri Mandal; Mariza de Andrade; Colette Gaba; Ping Yang; Yafang Li; Ming You; Ramaswamy Govindan; Richard K Wilson; Elena Y Kupert; Marshall W Anderson; Ann G Schwartz; Susan M Pinney; Christopher I Amos; Joan E Bailey-Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-11       Impact factor: 4.254

5.  Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.

Authors:  Richarda M de Voer; Marc-Manuel Hahn; Robbert D A Weren; Arjen R Mensenkamp; Christian Gilissen; Wendy A van Zelst-Stams; Liesbeth Spruijt; C Marleen Kets; Junxiao Zhang; Hanka Venselaar; Lilian Vreede; Nil Schubert; Marloes Tychon; Ronny Derks; Hans K Schackert; Ad Geurts van Kessel; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  PLoS Genet       Date:  2016-02-22       Impact factor: 5.917

Review 6.  The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery.

Authors:  M M Hahn; R M de Voer; N Hoogerbrugge; M J L Ligtenberg; R P Kuiper; A Geurts van Kessel
Journal:  Cell Oncol (Dordr)       Date:  2016-06-09       Impact factor: 6.730

Review 7.  Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future Studies.

Authors:  Iris B A W Te Paske; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge; Richarda M de Voer
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

8.  Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancer.

Authors:  Vittoria Disciglio; Andrea Devecchi; Orazio Palumbo; Massimo Carella; Donata Penso; Massimo Milione; Giorgio Valle; Marco Alessandro Pierotti; Marco Vitellaro; Lucio Bertario; Silvana Canevari; Stefano Signoroni; Loris De Cecco
Journal:  Chin J Cancer       Date:  2016-06-07

9.  Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer.

Authors:  Wenwen Xue; Xin Li; Qiang Xu; Wuhao Li; Yixuan Wang; Chengfei Jiang; Lin Zhou; Jian Gao; Ying Yu; Yan Shen
Journal:  Signal Transduct Target Ther       Date:  2022-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.